{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T06:40:29Z","timestamp":1757313629222},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2010,3,13]],"date-time":"2010-03-13T00:00:00Z","timestamp":1268438400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1007\/s00467-010-1477-2","type":"journal-article","created":{"date-parts":[[2010,3,12]],"date-time":"2010-03-12T12:39:45Z","timestamp":1268397585000},"page":"1139-1146","source":"Crossref","is-referenced-by-count":10,"title":["Chronic treatment with lisinopril decreases proliferative and apoptotic pathways in autosomal recessive polycystic kidney disease"],"prefix":"10.1007","volume":"25","author":[{"given":"Guangfu","family":"Jia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huan Ling","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jordan","family":"Mortensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vani","family":"Nilakantan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William E.","family":"Sweeney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,3,13]]},"reference":[{"key":"1477_CR1","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s00441-006-0226-0","volume":"326","author":"WE Sweeney Jr","year":"2006","unstructured":"Sweeney WE Jr, Avner ED (2006) Molecular and cellular pathophysiology of autosomal recessive polycystic kidney disease (ARPKD). Cell Tissue Res 326:671\u2013685","journal-title":"Cell Tissue Res"},{"key":"1477_CR2","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1086\/340448","volume":"70","author":"LF Onuchic","year":"2002","unstructured":"Onuchic LF, Furu L, Nagasawa Y, Hou X, Eggermann T, Ren Z, Bergmann C, Senderek J, Esquivel E, Zeltner R, Rudnik-Schoneborn S, Mrug M, Sweeney W, Avner ED, Zerres K, Guay-Woodford LM, Somlo S, Germino GG (2002) PKHD1, the polycystic kidney and hepatic disease 1 gene, encodes a novel large protein containing multiple immunoglobulin-like plexin-transcription-factor domains and parallel beta-helix 1 repeats. Am J Hum Genet 70:1305\u20131317","journal-title":"Am J Hum Genet"},{"key":"1477_CR3","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/ng833","volume":"30","author":"CJ Ward","year":"2002","unstructured":"Ward CJ, Hogan MC, Rossetti S, Walker D, Sneddon T, Wang X, Kubly V, Cunningham JM, Bacallao R, Ishibashi M, Milliner DS, Torres VE, Harris PC (2002) The gene mutated in autosomal recessive polycystic kidney disease encodes a large, receptor-like protein. Nat Genet 30:259\u2013269","journal-title":"Nat Genet"},{"key":"1477_CR4","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1159\/000052624","volume":"9","author":"F Bonnet","year":"2001","unstructured":"Bonnet F, Cao Z, Cooper ME (2001) Apoptosis and angiotensin II: yet another renal regulatory system? Exp Nephrol 9:295\u2013300","journal-title":"Exp Nephrol"},{"key":"1477_CR5","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1038\/nm1275","volume":"11","author":"A Lautrette","year":"2005","unstructured":"Lautrette A, Li S, Alili R, Sunnarborg SW, Burtin M, Lee DC, Friedlander G, Terzi F (2005) Angiotensin II and EGF receptor cross-talk in chronic kidney diseases: a new therapeutic approach. Nat Med 11:867\u2013874","journal-title":"Nat Med"},{"key":"1477_CR6","doi-asserted-by":"crossref","first-page":"15022","DOI":"10.1074\/jbc.273.24.15022","volume":"273","author":"M Ushio-Fukai","year":"1998","unstructured":"Ushio-Fukai M, Alexander RW, Akers M, Griendling KK (1998) p38 Mitogen-activated protein kinase is a critical component of the redox-sensitive signaling pathways activated by angiotensin II. Role in vascular smooth muscle cell hypertrophy. J Biol Chem 273:15022\u201315029","journal-title":"J Biol Chem"},{"key":"1477_CR7","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3317\/jraas.2007.003","volume":"8","author":"JL Zhuo","year":"2007","unstructured":"Zhuo JL, Li XC (2007) Novel roles of intracrine angiotensin II and signalling mechanisms in kidney cells. J Renin Angiotensin Aldosterone Syst 8:23\u201333","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"1477_CR8","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1590\/S0100-879X2009000100007","volume":"42","author":"AP Balbi","year":"2009","unstructured":"Balbi AP, Francescato HD, Marin EC, Costa RS, Coimbra TM (2009) Roles of mitogen-activated protein kinases and angiotensin II in renal development. Braz J Med Biol Res 42:38\u201343","journal-title":"Braz J Med Biol Res"},{"key":"1477_CR9","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.2215\/CJN.05651207","volume":"3","author":"JP Calvet","year":"2008","unstructured":"Calvet JP (2008) Strategies to inhibit cyst formation in ADPKD. Clin J Am Soc Nephrol 3:1205\u20131211","journal-title":"Clin J Am Soc Nephrol"},{"key":"1477_CR10","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/nrd1177","volume":"2","author":"S Kumar","year":"2003","unstructured":"Kumar S, Boehm J, Lee JC (2003) p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseases. Nat Rev Drug Discov 2:717\u2013726","journal-title":"Nat Rev Drug Discov"},{"key":"1477_CR11","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1128\/MCB.19.4.2435","volume":"19","author":"HJ Schaeffer","year":"1999","unstructured":"Schaeffer HJ, Weber MJ (1999) Mitogen-activated protein kinases: specific messages from ubiquitous messengers. Mol Cell Biol 19:2435\u20132444","journal-title":"Mol Cell Biol"},{"key":"1477_CR12","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1681\/ASN.V124719","volume":"12","author":"K Nakanishi","year":"2001","unstructured":"Nakanishi K, Sweeney WE Jr, Macrae Dell K, Cotton CU, Avner ED (2001) Role of CFTR in autosomal recessive polycystic kidney disease. J Am Soc Nephrol 12:719\u2013725","journal-title":"J Am Soc Nephrol"},{"key":"1477_CR13","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1172\/JCI2071","volume":"101","author":"WG Richards","year":"1998","unstructured":"Richards WG, Sweeney WE, Yoder BK, Wilkinson JE, Woychik RP, Avner ED (1998) Epidermal growth factor receptor activity mediates renal cyst formation in polycystic kidney disease. J Clin Invest 101:935\u2013939","journal-title":"J Clin Invest"},{"key":"1477_CR14","doi-asserted-by":"crossref","first-page":"C1695","DOI":"10.1152\/ajpcell.2001.281.5.C1695","volume":"281","author":"WE Sweeney Jr","year":"2001","unstructured":"Sweeney WE Jr, Kusner L, Carlin CR, Chang S, Futey L, Cotton CU, Dell KM, Avner ED (2001) Phenotypic analysis of conditionally immortalized cells isolated from the BPK model of ARPKD. Am J Physiol Cell Physiol 281:C1695\u2013C1705","journal-title":"Am J Physiol Cell Physiol"},{"key":"1477_CR15","doi-asserted-by":"crossref","first-page":"F575","DOI":"10.1152\/ajprenal.90705.2008","volume":"296","author":"F Park","year":"2009","unstructured":"Park F, Sweeney WE Jr, Jia G, Akbulut T, Mueller B, Falck JR, Birudaraju S, Roman RJ, Avner ED (2009) Chronic blockade of 20-HETE synthesis reduces polycystic kidney disease in an orthologous rat model of ARPKD. Am J Physiol Renal Physiol 296:F575\u2013F582","journal-title":"Am J Physiol Renal Physiol"},{"key":"1477_CR16","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1046\/j.1523-1755.2001.00473.x","volume":"59","author":"DJ Lager","year":"2001","unstructured":"Lager DJ, Qian Q, Bengal RJ, Ishibashi M, Torres VE (2001) The pck rat: a new model that resembles human autosomal dominant polycystic kidney and liver disease. Kidney Int 59:126\u2013136","journal-title":"Kidney Int"},{"key":"1477_CR17","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1542\/peds.111.5.1072","volume":"111","author":"LM Guay-Woodford","year":"2003","unstructured":"Guay-Woodford LM, Desmond RA (2003) Autosomal recessive polycystic kidney disease: the clinical experience in North America. Pediatrics 111:1072\u20131080","journal-title":"Pediatrics"},{"key":"1477_CR18","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/j.1651-2227.1996.tb14056.x","volume":"85","author":"K Zerres","year":"1996","unstructured":"Zerres K, Rudnik-Schoneborn S, Deget F, Holtkamp U, Brodehl J, Geisert J, Scharer K (1996) Autosomal recessive polycystic kidney disease in 115 children: clinical presentation, course and influence of gender. Acta Paediatr 85:437\u2013445","journal-title":"Acta Paediatr"},{"key":"1477_CR19","first-page":"453","volume":"16","author":"K Zerres","year":"2003","unstructured":"Zerres K, Rudnik-Schoneborn S, Senderek J, Eggermann T, Bergmann C (2003) Autosomal recessive polycystic kidney disease (ARPKD). J Nephrol 16:453\u2013458","journal-title":"J Nephrol"},{"key":"1477_CR20","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s00467-002-1021-0","volume":"18","author":"R Capisonda","year":"2003","unstructured":"Capisonda R, Phan V, Traubuci J, Daneman A, Balfe JW, Guay-Woodford LM (2003) Autosomal recessive polycystic kidney disease: outcomes from a single-center experience. Pediatr Nephrol 18:119\u2013126","journal-title":"Pediatr Nephrol"},{"key":"1477_CR21","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/BF00859625","volume":"3","author":"BS Kaplan","year":"1989","unstructured":"Kaplan BS, Fay J, Shah V, Dillon MJ, Barratt TM (1989) Autosomal recessive polycystic kidney disease. Pediatr Nephrol 3:43\u201349","journal-title":"Pediatr Nephrol"},{"key":"1477_CR22","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0272-6386(12)80907-3","volume":"24","author":"DS Keith","year":"1994","unstructured":"Keith DS, Torres VE, Johnson CM, Holley KE (1994) Effect of sodium chloride, enalapril, and losartan on the development of polycystic kidney disease in Han:SPRD rats. Am J Kidney Dis 24:491\u2013498","journal-title":"Am J Kidney Dis"},{"key":"1477_CR23","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1046\/j.1523-1755.1999.00783.x","volume":"56","author":"TM Kennefick","year":"1999","unstructured":"Kennefick TM, Al-Nimri MA, Oyama TT, Thompson MM, Kelly FJ, Chapman JG, Anderson S (1999) Hypertension and renal injury in experimental polycystic kidney disease. Kidney Int 56:2181\u20132190","journal-title":"Kidney Int"},{"key":"1477_CR24","doi-asserted-by":"crossref","first-page":"F854","DOI":"10.1152\/ajprenal.00059.2007","volume":"293","author":"I Zafar","year":"2007","unstructured":"Zafar I, Tao Y, Falk S, McFann K, Schrier RW, Edelstein CL (2007) Effect of statin and angiotensin-converting enzyme inhibition on structural and hemodynamic alterations in autosomal dominant polycystic kidney disease model. Am J Physiol Renal Physiol 293:F854\u2013F859","journal-title":"Am J Physiol Renal Physiol"},{"key":"1477_CR25","first-page":"S71","volume":"61","author":"AB Chapman","year":"1997","unstructured":"Chapman AB, Gabow PA (1997) Hypertension in autosomal dominant polycystic kidney disease. Kidney Int Suppl 61:S71\u2013S73","journal-title":"Kidney Int Suppl"},{"key":"1477_CR26","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1056\/NEJM199010183231602","volume":"323","author":"AB Chapman","year":"1990","unstructured":"Chapman AB, Johnson A, Gabow PA, Schrier RW (1990) The renin-angiotensin-aldosterone system and autosomal dominant polycystic kidney disease. N Engl J Med 323:1091\u20131096","journal-title":"N Engl J Med"},{"key":"1477_CR27","doi-asserted-by":"crossref","first-page":"393","DOI":"10.2147\/TCRM.S1617","volume":"4","author":"A Masoumi","year":"2008","unstructured":"Masoumi A, Reed-Gitomer B, Kelleher C, Bekheirnia MR, Schrier RW (2008) Developments in the management of autosomal dominant polycystic kidney disease. Ther Clin Risk Manag 4:393\u2013407","journal-title":"Ther Clin Risk Manag"},{"key":"1477_CR28","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1159\/000101828","volume":"30","author":"JK Phillips","year":"2007","unstructured":"Phillips JK, Hopwood D, Loxley RA, Ghatora K, Coombes JD, Tan YS, Harrison JL, McKitrick DJ, Holobotvskyy V, Arnolda LF, Rangan GK (2007) Temporal relationship between renal cyst development, hypertension and cardiac hypertrophy in a new rat model of autosomal recessive polycystic kidney disease. Kidney Blood Press Res 30:129\u2013144","journal-title":"Kidney Blood Press Res"},{"key":"1477_CR29","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1046\/j.1523-1755.2002.00273.x","volume":"61","author":"M Hida","year":"2002","unstructured":"Hida M, Omori S, Awazu M (2002) ERK and p38 MAP kinase are required for rat renal development. Kidney Int 61:1252\u20131262","journal-title":"Kidney Int"},{"key":"1477_CR30","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1681\/ASN.2004090800","volume":"17","author":"S Omori","year":"2006","unstructured":"Omori S, Hida M, Fujita H, Takahashi H, Tanimura S, Kohno M, Awazu M (2006) Extracellular signal-regulated kinase inhibition slows disease progression in mice with polycystic kidney disease. J Am Soc Nephrol 17:1604\u20131614","journal-title":"J Am Soc Nephrol"},{"key":"1477_CR31","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1046\/j.1523-1755.2002.00250.x","volume":"61","author":"T Ecder","year":"2002","unstructured":"Ecder T, Melnikov VY, Stanley M, Korular D, Lucia MS, Schrier RW, Edelstein CL (2002) Caspases, Bcl-2 proteins and apoptosis in autosomal-dominant polycystic kidney disease. Kidney Int 61:1220\u20131230","journal-title":"Kidney Int"},{"key":"1477_CR32","doi-asserted-by":"crossref","first-page":"6954","DOI":"10.1073\/pnas.0408518102","volume":"102","author":"Y Tao","year":"2005","unstructured":"Tao Y, Kim J, Faubel S, Wu JC, Falk SA, Schrier RW, Edelstein CL (2005) Caspase inhibition reduces tubular apoptosis and proliferation and slows disease progression in polycystic kidney disease. Proc Natl Acad Sci U\u00a0S\u00a0A 102:6954\u20136959","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"key":"1477_CR33","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1111\/j.1523-1755.2005.00155.x","volume":"67","author":"Y Tao","year":"2005","unstructured":"Tao Y, Kim J, Stanley M, He Z, Faubel S, Schrier RW, Edelstein CL (2005) Pathways of caspase-mediated apoptosis in autosomal-dominant polycystic kidney disease (ADPKD). Kidney Int 67:909\u2013919","journal-title":"Kidney Int"},{"key":"1477_CR34","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1681\/ASN.2006121378","volume":"19","author":"Y Tao","year":"2008","unstructured":"Tao Y, Zafar I, Kim J, Schrier RW, Edelstein CL (2008) Caspase-3 gene deletion prolongs survival in polycystic kidney disease. J Am Soc Nephrol 19:749\u2013755","journal-title":"J Am Soc Nephrol"},{"key":"1477_CR35","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/sj.ki.5002695","volume":"73","author":"BD Cowley Jr","year":"2008","unstructured":"Cowley BD Jr (2008) Calcium, cyclic AMP, and MAP kinases: dysregulation in polycystic kidney disease. Kidney Int 73:251\u2013253","journal-title":"Kidney Int"},{"key":"1477_CR36","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1146\/annurev.biochem.68.1.383","volume":"68","author":"WC Earnshaw","year":"1999","unstructured":"Earnshaw WC, Martins LM, Kaufmann SH (1999) Mammalian caspases: structure, activation, substrates, and functions during apoptosis. Annu Rev Biochem 68:383\u2013424","journal-title":"Annu Rev Biochem"},{"key":"1477_CR37","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1097-2765(02)00482-3","volume":"9","author":"Y Shi","year":"2002","unstructured":"Shi Y (2002) Mechanisms of caspase activation and inhibition during apoptosis. Mol Cell 9:459\u2013470","journal-title":"Mol Cell"},{"key":"1477_CR38","doi-asserted-by":"crossref","first-page":"20049","DOI":"10.1074\/jbc.274.29.20049","volume":"274","author":"BB Wolf","year":"1999","unstructured":"Wolf BB, Green DR (1999) Suicidal tendencies: apoptotic cell death by caspase family proteinases. J Biol Chem 274:20049\u201320052","journal-title":"J Biol Chem"},{"key":"1477_CR39","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0092-8674(93)80065-M","volume":"75","author":"DJ Veis","year":"1993","unstructured":"Veis DJ, Sorenson CM, Shutter JR, Korsmeyer SJ (1993) Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair. Cell 75:229\u2013240","journal-title":"Cell"},{"key":"1477_CR40","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1007\/BF00858681","volume":"2","author":"H Kaariainen","year":"1988","unstructured":"Kaariainen H, Koskimies O, Norio R (1988) Dominant and recessive polycystic kidney disease in children: evaluation of clinical features and laboratory data. Pediatr Nephrol 2:296\u2013302","journal-title":"Pediatr Nephrol"},{"key":"1477_CR41","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1046\/j.1523-1755.2003.00185.x","volume":"64","author":"AB Chapman","year":"2003","unstructured":"Chapman AB, Guay-Woodford LM, Grantham JJ, Torres VE, Bae KT, Baumgarten DA, Kenney PJ, King BF Jr, Glockner JF, Wetzel LH, Brummer ME, O'Neill WC, Robbin ML, Bennett WM, Klahr S, Hirschman GH, Kimmel PL, Thompson PA, Miller JP (2003) Renal structure in early autosomal-dominant polycystic kidney disease (ADPKD): The Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) cohort. Kidney Int 64:1035\u20131045","journal-title":"Kidney Int"},{"key":"1477_CR42","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1681\/ASN.V561349","volume":"5","author":"AB Chapman","year":"1994","unstructured":"Chapman AB, Johnson AM, Gabow PA, Schrier RW (1994) Overt proteinuria and microalbuminuria in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 5:1349\u20131354","journal-title":"J Am Soc Nephrol"},{"key":"1477_CR43","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1159\/000046231","volume":"21","author":"T Ecder","year":"2001","unstructured":"Ecder T, Edelstein CL, Fick-Brosnahan GM, Johnson AM, Chapman AB, Gabow PA, Schrier RW (2001) Diuretics versus angiotensin-converting enzyme inhibitors in autosomal dominant polycystic kidney disease. Am J Nephrol 21:98\u2013103","journal-title":"Am J Nephrol"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-010-1477-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00467-010-1477-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-010-1477-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,24]],"date-time":"2021-10-24T15:37:47Z","timestamp":1635089867000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00467-010-1477-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3,13]]},"references-count":43,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["1477"],"URL":"https:\/\/doi.org\/10.1007\/s00467-010-1477-2","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,3,13]]}}}